Burzynski Clinic [clinicaltrials_resource:17bb8261f7cfeca9088c67712b718fbf]
Antineoplaston Therapy in Treating Patients With Stage IV Bladder Cancer or Stage IV Newly Diagnosed, Incurable Bladder Cancer [clinicaltrials:NCT00003452]Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer [clinicaltrials:NCT00003454]Antineoplaston Therapy in Treating Women With Advanced Breast Cancer [clinicaltrials:NCT00003455]Antineoplaston Therapy in Treating Patients With Glioblastoma Multiforme [clinicaltrials:NCT00003456]Antineoplaston Therapy in Treating Patients With Brain Stem Glioma [clinicaltrials:NCT00003459]Antineoplaston Therapy in Treating Children With Primitive Neuroectodermal Tumors [clinicaltrials:NCT00003460]Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System [clinicaltrials:NCT00003469]Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma [clinicaltrials:NCT00003471]Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma [clinicaltrials:NCT00003472]Antineoplaston Therapy in Treating Patients With Ependymoma [clinicaltrials:NCT00003479]Antineoplaston Therapy in Treating Patients With Meningioma [clinicaltrials:NCT00003483]Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer [clinicaltrials:NCT00003485]Antineoplaston Therapy in Treating Patients With Colon Cancer [clinicaltrials:NCT00003486]Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus [clinicaltrials:NCT00003487]Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer [clinicaltrials:NCT00003489]Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer [clinicaltrials:NCT00003491]Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer [clinicaltrials:NCT00003492]Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer [clinicaltrials:NCT00003494]Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer [clinicaltrials:NCT00003495]Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer [clinicaltrials:NCT00003496]Antineoplaston Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer [clinicaltrials:NCT00003497]Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003498]Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003499]Antineoplaston Therapy in Treating Patients With Refractory or Recurrent Intermediate-Grade Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003500]Antineoplaston Therapy in Treating Patients With Recurrent or Refractory High-Grade Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003501]Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma [clinicaltrials:NCT00003502]Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma [clinicaltrials:NCT00003505]Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma [clinicaltrials:NCT00003508]Antineoplaston Therapy in Treating Patients With Stage IV Melanoma [clinicaltrials:NCT00003509]Antineoplaston Therapy in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003511]Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia [clinicaltrials:NCT00003512]Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma [clinicaltrials:NCT00003513]Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy [clinicaltrials:NCT00003514]Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors [clinicaltrials:NCT00003515]Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer [clinicaltrials:NCT00003516]Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer [clinicaltrials:NCT00003517]Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer [clinicaltrials:NCT00003520]Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma [clinicaltrials:NCT00003521]Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine [clinicaltrials:NCT00003522]Antineoplaston Therapy in Treating Patients With Stomach Cancer [clinicaltrials:NCT00003524]
location [clinicaltrials_vocabulary:location]
Burzynski Clinic [clinicaltrials_resource:17bb8261f7cfeca9088c67712b718fbf]
Bio2RDF identifier
17bb8261f7cfeca9088c67712b718fbf
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:17bb8261f7cfeca9088c67712b718fbf
address [clinicaltrials_vocabulary:address]
identifier
clinicaltrials_resource:17bb8261f7cfeca9088c67712b718fbf
title
Burzynski Clinic
@en
type
label
Burzynski Clinic [clinicaltrials_resource:17bb8261f7cfeca9088c67712b718fbf]
@en